+499.5%
MRNA vs BB
+105.3%
+394.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BB | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | 0.0% | -2.2% | -2.2% |
| 7D | +5.5% | -5.6% | +11.1% | +5.3% |
| 30D | +158.7% | -11.8% | +170.5% | +158.9% |
| 3M | +182.1% | -25.5% | +207.7% | +187.4% |
| 6M | +151.8% | +121.3% | +30.6% | +139.7% |
| YTD | +393.6% | +103.2% | +290.4% | +366.0% |
| 1Y | +499.5% | +102.6% | +396.8% | +479.8% |
| All | +499.5% | +105.3% | +394.1% | +479.8% |
Cumulative growth
Daily Returns
Daily percentage return beside BB.
Daily Out/Under-Performance
Portfolio return minus BB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling